Orca Bio, a biotechnology company focused on cell therapy, has received FDA approval for its new treatment, TREGZI, aimed at improving survival rates for blood cancer transplant patients. This development is set to significantly boost biotech jobs in Sacramento, where the company has already tripled its workforce over the past year to approximately 250 employees. The CEO highlighted Sacramento’s collaboration with local educational institutions as key to talent recruitment, and expressed intentions for continued growth in the manufacturing sector to meet rising demand for their therapies.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://www.kcra.com/article/orca-bio-bringing-biotech-jobs-to-sacramento/71942431
